Genetic stability of recombinant MVA-BN

Vaccine

Volumn 24, Issue 21, 2006, Pages 4618-4621

  Timm, Alexandra ^a   Enzinger, Christiane ^a   Felder, Eva ^a   Chaplin, Paul ^a  

^a Bavarian Nordic GmbH   (Germany)

Author keywords

Genetic stability; MVA; Vaccine

Indexed keywords

GAG PROTEIN; MVA BN; POL PROTEIN; RECOMBINANT VACCINE; SPACER DNA; TRANSACTIVATOR PROTEIN; VACCINIA VACCINE;

ARTICLE; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; GENETIC STABILITY; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS ATTENUATION;

GENE EXPRESSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 33646836983     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.037     Document Type: Article

References (5)

1. Mayr A., Hochstein-Mintzel V., and Stickl H. Abstammung, Eigenschaften und Verwendung des attenuierten Vaccinia-Stammes MVA. Infection 3 (1975) 6-14
2. Werner G.T., Jentzsch U., Metzger E., and Simon J. Studies on poxvirus infections in irradiated animals. Arch Virolol 64 (1980) 247-256
3. Stickl H., Hochstein-Mintzel V., Mayr A., Huber H., Schaefer H., and Holzner A. MVA-Stufenimpfung gegen Pocken. Deutsche medizinische Wochenschrift 99 (1974) 2386-2392
4. Mahnel H., and Mayr A. Erfahrungen bei der Schutzimpfung gegen Orthopocken von Mensch und Tier mit dem Impfstamm MVA. Berliner und Muenchener Tieraerztliche Wochenschrift 107 (1994) 253-256
5. Meyer H., Sutter G., and Mayr A. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J Gen Virol 72 (1991) 1031-1038